PES1 promotes breast cancer by differentially regulating ER[alpha] and ERß
The initiation of breast cancer is associated with increased expression of tumor-promoting estrogen receptor α (ERα) protein and decreased expression of tumor-suppressive ERß protein. However, the mechanism underlying this process is unknown. Here we show that PES1 (also known as Pescadillo), an est...
Saved in:
Published in | The Journal of clinical investigation Vol. 122; no. 8; p. 2857 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ann Arbor
American Society for Clinical Investigation
01.08.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The initiation of breast cancer is associated with increased expression of tumor-promoting estrogen receptor α (ERα) protein and decreased expression of tumor-suppressive ERß protein. However, the mechanism underlying this process is unknown. Here we show that PES1 (also known as Pescadillo), an estrogen-inducible protein that is overexpressed in breast cancer, can regulate the balance between ERα and ERß. We found that PES1 modulated many estrogen-responsive genes by enhancing the transcriptional activity of ERα while inhibiting transcriptional activity of ERß. Consistent with this regulation of ERα and ERß transcriptional activity, PES1 increased the stability of the ERα protein and decreased that of ERß through the ubiquitin-proteasome pathway, mediated by the carboxyl terminus of Hsc70-interacting protein (CHIP). Moreover, PES1 transformed normal human mammary epithelial cells and was required for estrogen-induced breast tumor growth in nude mice. Further analysis of clinical samples showed that expression of PES1 correlated positively with ERα expression and negatively with ERß expression and predicted good clinical outcome in breast cancer. Our data demonstrate that PES1 contributes to breast tumor growth through regulating the balance between ERα and ERß and may be a better target for the development of drugs that selectively regulate ERα and ERß activities. [PUBLICATION ABSTRACT] |
---|---|
ISSN: | 0021-9738 1558-8238 |